RWM
PDSB icon

Ritholtz Wealth Management’s PDS Biotechnology PDSB Stock Holding History

Ritholtz Wealth Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,659
Closed -$23.4K – 1029
2025
Q1 		$23.4K Buy
+19,659
New +$28K ﹤0.01% 920

Other funds holding PDSB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ritholtz Wealth Management's PDSB Position: Q2 2025 in Review

Ritholtz Wealth Management sold out of PDS Biotechnology (PDSB) in Q2 2025, closing a stake of 19,659 shares — an estimated $23.4K sold.

Ritholtz Wealth Management first reported a position in PDSB in Q1 2025 and held it in 1 quarter. The position peaked at $23.4K in Q1 2025. 55 funds tracked by Wall St. Rank hold PDSB as of Q2 2025.

  • Ritholtz Wealth Management reported no remaining PDS Biotechnology position as of Q2 2025 after selling out during the quarter.
  • Ritholtz Wealth Management sold 19,659 PDS Biotechnology shares in Q2 2025, an estimated $23.4K.
  • Ritholtz Wealth Management first reported a position in PDS Biotechnology in Q1 2025 and held it in 1 quarter.
  • Ritholtz Wealth Management's PDS Biotechnology position peaked at $23.4K in Q1 2025.
  • 55 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2025.

Based on Ritholtz Wealth Management's 13F filing for Q2 2025, filed 28 Jul 2025.